• Rowe v. Bell & Gossett Company, et al., 239 N.J. 531 (2019) (upheld trial court’s admission in evidence of excerpts of settling defendants’ interrogatory answers and their corporate representatives’ depositions, resulting in reversal of Appellate Division decision and reinstatement of jury verdict apportioning fault to settling defendants)
• Pop Test Cortisol LLC v. Merck & Co. Inc., 2014 WL 1660605 (NJ Super. Ct. App. Div. Apr. 28, 2014) (order compelling arbitration of all claims by the licensee of a cortisol-blocking drug against the licensor affirmed)
• Heindel v. Pfizer Inc., 381 F.Supp.2d 364 (D.N.J. 2004) (summary judgment granted to pharmaceutical manufacturers in a putative class action in which plaintiffs claimed they paid inflated prices for prescription drugs due to the concealment of cardiac problems allegedly associated with the drugs)
• Doe v. Greater New York Blood Program, 304 NJ Super. 287 (App. Div. 1997) (based on state of scientific knowledge blood center had no duty in January 1982 to implement high-risk screening procedures or testing for potentially HIV-infected donors)
• Vitrano v. Schiffman, 305 NJ Super. 572 (App. Div. 1997) (dismissal of physicians affirmed where the plaintiff’s expert was unable to establish causation within medical probability)